leadf
logo-loader
viewInnoCan Pharma
(
CSE:INNO
)

Innocan Pharma teams up with Endless Sky to manufacturer and distribute its CBD products

Innocan Pharma Corporation (CSE:INNO) CEO Iris Bincovich and Endless Sky CEO Travis George tells Proactive the two have signed a manufacturing and distribution agreement.

Bincovich says Endless Sky will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its Health Canada-licensed facility in Redvers, Saskatchewan.

In exchange, ESI will pay Innocan Israel a fee per product in addition to royalties based on net sales.

Quick facts: InnoCan Pharma

Follow
CSE:INNO

Price: 1.42 CAD

Market Cap: $312.25 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Emmaus Life Sciences progressing with expanding availability of lead drug...

Emmaus Life Sciences Inc CEO Yutaka Niihara joined Proactive to discuss the Torrance, California-based group's focus on expanding its FDA approved drug, Endari, to treat sickle cell disease internationally, specifically focusing in on the Middle East. Niihara says recently, the National...

1 hour, 9 minutes ago

2 min read